Search results
PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed...
Benzinga via Yahoo Finance· 12 months agoPTC Therapeutics Inc (NASDAQ: PTCT) reported topline results from the MOVE-FA trial of vatiquinone...
PTC Therapeutics Stock Sees IBD RS Rating Climb To 72
Investor's Business Daily· 2 weeks agoPTC Therapeutics stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday,...
PTC Therapeutics' Barrage Of Bad News Is Good News For Rival Reata Pharmaceuticals — Here's Why
Investor's Business Daily· 12 months agoPTC stock plummeted Wednesday and gave its closest rival a boost after the company's treatment for a...
Why PTC Therapeutics Could Be Victorious In Its Rare-Disease Battle Against BioMarin Pharmaceuticals
Investor's Business Daily· 1 year agoPTC stock surged Wednesday after the biotech company unveiled promising results for its rare disease...
PTC Therapeutics Says Interim Data For Huntington's Disease Candidate Shows Promise In Mid-Stage...
Benzinga via Yahoo Finance· 11 months agoPTC Therapeutics Inc (NASDAQ: PTCT) shared interim data from the 12-week portion of the PIVOT-HD...
Why PTC Therapeutics Shares Are Gaining Today
Benzinga via Yahoo Finance· 1 year agoPTC Therapeutics Inc (NASDAQ: PTCT) says its APHENITY Phase 3 trial of sepiapterin in adult and pediatric patients with phenylketonuria (PKU) has...
Dow Jones Futures Fall As Market Rally Retreats Amid Debt-Ceiling Drama; Nvidia Earnings Due
Investor's Business Daily· 12 months agoDow Jones futures fell slightly early Wednesday, along with S&P 500 futures and Nasdaq futures....
Reata (RETA) Stock Jumps as FDA Approves Rare Disease Drug
Zacks via Yahoo Finance· 1 year agoSkyclarys is the first drug to be approved specifically for the treatment of Friedreich's ataxia and...
PTC Therapeutics says interim data for Huntington's disease drug shows promise
Reuters via Yahoo News· 11 months agoHuntington's is a rare disease caused by a defective gene that produces an abnormal level of protein, called Huntingtin, which is involved in the functioning of the nerve cells in the brain.
Reaction Is Overdone For PTC Therapeutics Pausing Huntington Trial Enrollment, Analyst Says
Benzinga via Yahoo Finance· 2 years agoEarlier today, the FDA requested additional data to allow a 12-week portion of the Phase 2 PIVOT-HD...
